Patents by Inventor Eun Hee Yeon

Eun Hee Yeon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for using information on complex biomarker group to diagnose lung cancer in a subject and diagnostic kit and computing system using the same
    Patent number: 10663469
    Abstract: A method for diagnosing lung cancer in a subject by using a complex biomarker group is provided. The method includes steps of: (a) a computing system (1) acquiring a model M by using expression level data by individual biomarkers in the complex biomarker group and then (2) acquiring expression level data by the individual biomarkers measured from a biological specimen of the subject or their processed data Bk; and (b) the computing system determining whether lung cancer is detected in the subject by using the acquired data of the subject by referring to the model M; wherein the complex biomarker group includes CEA, HE4, ApoA2, TTR, sVCAM-1 and RANTES.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: May 26, 2020
    Assignee: BioInfra Life Science Inc.
    Inventors: Chul Woo Kim, Yong Dai Kim, Yong Sung Shin, Eun Hee Yeon, Kyung Nam Kang, Ho Sang Shin, Oh Ran Kwon
  • METHOD FOR USING INFORMATION ON COMPLEX BIOMARKER GROUP TO DIAGNOSE LUNG CANCER IN A SUBJECT AND DIAGNOSTIC KIT AND COMPUTING SYSTEM USING THE SAME
    Publication number: 20180067118
    Abstract: A method for diagnosing lung cancer in a subject by using a complex biomarker group is provided. The method includes steps of: (a) a computing system (1) acquiring a model M by using expression level data by individual biomarkers in the complex biomarker group and then (2) acquiring expression level data by the individual biomarkers measured from a biological specimen of the subject or their processed data Bk; and (b) the computing system determining whether lung cancer is detected in the subject by using the acquired data of the subject by referring to the model M; wherein the complex biomarker group includes CEA, HE4, ApoA2, TTR, sVCAM-1 and RANTES.
    Type: Application
    Filed: February 10, 2017
    Publication date: March 8, 2018
    Inventors: Chul Woo Kim, Yong Dai Kim, Yong Sung Shin, Eun Hee Yeon, Kyung Nam Kang, Ho Sang Shin, Oh Ran Kwon